Neurosurgery (NS) is essential for the treatment of various diseases such as malignant tumors, vascular conditions, spinal stenosis or trauma. However, NS can be complicated by the onset of infections, directly related to surgery or to hospitalization. Little is known regarding the epidemiology, the optimal treatment regimens and the outcome of infections following NS (I-NS). The study aims at investigating the clinical and microbiological characteristics as well as the outcomes of I-NS occurring at a single Institution (IRCCS Neuromed, Pozzilli, Italy) during the period 2016-2018. Patients with at least 1 infective episode requiring antimicrobial therapy are included in this retrospective observational study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of participants with sepsis/septic shock
Timeframe: From the date of inclusion until the date of sepsis/septic shock diagnosis, assessed up to 6 months
Number of participants with multi-drug resistant microorganisms
Timeframe: From the date of inclusion until the date of antimicrobial susceptibility report availability, assessed up to 6 months
mortality
Timeframe: 30-days